3C
CC icon

361 Capital’s Chemours CC Stock Holding History

361 Capital’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-33,240
Closed -$1.48M – 336
2018
Q2 		$1.48M Buy
+33,240
New +$1.65M 0.33% 187
2017
Q4 		– Sell
-38,202
Closed -$1.93M – 243
2017
Q3 		$1.93M Buy
+38,202
New +$1.8M 0.37% 150
2017
Q2 		– Sell
-5,710
Closed -$220K – 168
2017
Q1 		$220K Buy
+5,710
New +$172K 0.05% 134

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

361 Capital's CC Position: Q3 2018 in Review

361 Capital sold out of Chemours (CC) in Q3 2018, closing a stake of 33,240 shares — an estimated $1.48M sold.

361 Capital first reported a position in CC in Q1 2017 and held it in 3 quarters. The position peaked at $1.93M in Q3 2017. 551 funds tracked by Wall St. Rank hold CC as of Q3 2018.

  • 361 Capital reported no remaining Chemours position as of Q3 2018 after selling out during the quarter.
  • 361 Capital sold 33,240 Chemours shares in Q3 2018, an estimated $1.48M.
  • 361 Capital first reported a position in Chemours in Q1 2017 and held it in 3 quarters.
  • 361 Capital's Chemours position peaked at $1.93M in Q3 2017.
  • 551 funds tracked by Wall St. Rank held Chemours as of Q3 2018.

Based on 361 Capital's 13F filing for Q3 2018, filed 13 Nov 2018.